TILT Holdings Strengthens Compliance Team, Welcoming Nicole Moyers as Vice President of Compliance and Patrick Beyea as Director of Compliance
February 18, 2021 07:00 ET
|
TILT Holdings Inc.
Ms. Moyers served on the Pennsylvania Cannabis Coalition; Mr. Beyea served on the Massachusetts Cannabis Control Commission PHOENIX, Feb. 18, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT or...
TILT Holdings Provides Preliminary Fourth Quarter Results, Operational Highlights and 2021 Outlook
February 17, 2021 06:30 ET
|
TILT Holdings Inc.
Jupiter Q4 2020 revenues return to pre-COVID levels Standard Farms extraction capacity increased by 100% during Q4 2020 CAC lab and kitchen production capacity increased by 100% during Q4 2020 ...
TILT Holdings Inc. Congratulates Partner, Kanabo Group PLC, on Commencing Trading on the London Stock Exchange
February 16, 2021 07:30 ET
|
TILT Holdings Inc.
PHOENIX, Feb. 16, 2021 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCQX: TLLTF), a provider of business solutions to the global cannabis industry that includes...
EXMceuticals Inc. becomes member of the Portuguese Association of the Pharmaceutical Industry (APIFARMA).
September 29, 2020 09:00 ET
|
EXMceuticals Inc.
VANCOUVER, British Columbia, Sept. 29, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (OTCQB:EXM…, (the "Company" or "EXM"), an emerging bio-sciences company specializing in the...
EXMceuticals Inc. Announces Receipt of Landmark COVID-19 Research Grant and Acceleration of Portuguese Activities
September 08, 2020 09:00 ET
|
EXMceuticals Inc.
VANCOUVER, British Columbia, Sept. 08, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging bio-sciences company specializing in the production...
EXMceuticals Inc. Announces Advancement of R&D Operations in Portugal and Efforts to Fight COVID-19 Pandemic
August 25, 2020 08:00 ET
|
EXMceuticals Inc.
VANCOUVER, British Columbia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging bio-science company specializing in the production of...
EXMceuticals Inc. Announces Shares for Debt Settlement
August 21, 2020 21:16 ET
|
EXMceuticals Inc.
VANCOUVER, British Columbia, Aug. 21, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company”) announces that it has settled $1,378,241 of debt with creditors by issuing...
EXMceuticals Inc. Announces Loan Settlement and Share Issuance
July 28, 2020 16:39 ET
|
EXMceuticals Inc.
Not for distribution in the U.S. or to U.S. Newswire Services VANCOUVER, British Columbia, July 28, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the “Company” or “EXM”) is...
EXMceuticals Inc. Announces Closing of Oversubscribed Private Placement and Strategic Debt to Equity Conversion Strengthening the Corporation’s Balance Sheet
July 22, 2020 15:18 ET
|
EXMceuticals Inc.
Not for distribution in the U.S. or to U.S. Newswire Services VANCOUVER, British Columbia, July 22, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM") is...
EXMceuticals Inc. Strengthens Positioning as a Gateway to the European Market through Supply Agreement for THC Distillate
June 11, 2020 09:00 ET
|
EXMceuticals Inc.
VANCOUVER, British Columbia, June 11, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), is pleased to announce that it has entered into a letter of...